Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial

INTRODUCTION: Type 2 diabetes (T2D) and heart failure (HF) are a frequent combination, where treatment options remain limited. There has been increasing interest around the sodium–glucose cotransporter 2 (SGLT2) inhibitors and their use in patients with HF. Data on the effect of SGLT2 inhibitor use...

Descripción completa

Detalles Bibliográficos
Autores principales: Mordi, Natalie A, Mordi, Ify R, Singh, Jagdeep S, Baig, Fatima, Choy, Anna-Maria, McCrimmon, Rory J, Struthers, Allan D, Lang, Chim C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652490/
https://www.ncbi.nlm.nih.gov/pubmed/29042392
http://dx.doi.org/10.1136/bmjopen-2017-018097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652490/
https://www.ncbi.nlm.nih.gov/pubmed/29042392
http://dx.doi.org/10.1136/bmjopen-2017-018097

Ejemplares similares